Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer

Chinese Medical Journal

Volumn 113, Issue 11, 2000, Pages 1002-1006

  Zang, Zhijiang ^a   Xu, Hongyi ^a   Yu, Lizhang ^b   Yang, Delin ^a   Xie, Shusheng ^b   Shi, Yongfu ^a   Li, Zehui ^a   Li, Jiongming ^a   Wang, Jiansong ^a   Li, Malin ^c   Guo, Yinglu ^b   Gu, Fangliu ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c Yunnan Pharmacological Laboratories of Natural Products   (China)

Author keywords

Bladder cancer; Immunotherapy; Intravesical administration; Monoclonal antibody

Indexed keywords

IMMUNOTOXIN; MITOMYCIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; MALE; TRANSITIONAL CELL CARCINOMA;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMMUNOTHERAPY; IMMUNOTOXINS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 0342520810     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Battelli MG, Polito L, Bolognesi A, et al. Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line. Int J Cancer 1996;65:485-490.
2. Wawrzynczak EJ, Cumber AJ, Henry RV, et al. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, rincin A chain, Gelonin, and Momordin. Cancer Res 1990; 50:7519-7526.
3. Zhao C, Xie SS, Long ZZ, et al. Preparation of an anti-human immunotoxin against bladder carcinoma and its in vitro targeting cytotoxicity. Chin J Cancer 1992;14:109-111.
4. Ma AH, Xie SS, Yu LZ, et al. The production and characterization of a monoclonal antibody against human bladder carcinoma. Chin J Urol 1989;10:131-136.
5. Epenetos AA, Snook D, Durbin H, et al. Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 1986;46:3183-3191.
6. Hoffman T. Anticipating, recognizing and preventing hazards associated with in vivo used of monoclonal antibodies: special considerations related to human anti-mouse antibodies. Cancer Res 1990;50 (Suppl):1049-1050.
7. Griffin TW, Collins J, Bokhari F, et al. Intraperitoneal immunoconjugates. Cancer Res 1990;50 (Suppl):1031-1038.
8. Russell PJ, Plimley J, Raghavan D. The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer. Br J Urol 1993;71:121-129.
9. Perentesis JP, Waddick KG, Bendel AE, et al. Induction of apoptosis in multidrug-resistant and radiation-resistant acute myeloid leukemia cells by a recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor. Clin Cancer Res 1997;3:347-355.